Lodz City Tour: The Changing Nature of the Urban Restructuring of a Post-Socialist Industrial City

This paper describes the restructuring of Poland’s third-largest city, Lodz (Łódź). Once a thriving metropolitan hub of textile and clothing manufacturing, Lodz was confronted with the closure of its numerous factories in the early 1990s with Poland’s transition from a planned to a global market economy. The city suffered an abrupt and dramatic decline followed by a redefinition of its economic, spatial and social structures. The paper focuses on the major economic and spatial phenomena taking place in the city in the three decades after the economic collapse. Using an evolutionary approach, it identifies and discusses the gradual shift of Lodz’s restructuring. We claim that the restructuring initially involved mostly organic and spontaneous initiatives of dynamic local and non-local actors, with minor and circumstantial involvement from the local authorities. However, over time, the restructuring of Lodz has become influenced and driven by nationally and EU-set objectives and targeted urban policies, with urban and infrastructural projects as driving vehicles.Jakub Zasina’s portion of this work was supported by the National Science Centre in Poland (grant agreement no. 2016/23/N/HS4/03390)

Metabolic syndrome is associated with similar long-term prognosis in non-obese and obese patients. An analysis of 45 615 patients from the nationwide LIPIDOGRAM 2004-2015 cohort studies

Aims We aimed to evaluate the association between metabolic syndrome (MetS) and long-term all-cause mortality. Methods The LIPIDOGRAM studies were carried out in the primary care in Poland in 2004, 2006 and 2015. MetS was diagnosed based on the National Cholesterol Education Program, Adult Treatment Panel III (NCEP/ATP III) and Joint Interim Statement (JIS) criteria. The cohort was divided into four groups: non-obese patients without MetS, obese patients without MetS, non-obese patients with MetS and obese patients with MetS. Differences in all-cause mortality was analyzed using Kaplan-Meier and Cox regression analyses. Results 45,615 participants were enrolled (mean age 56.3, standard deviation: 11.8 years; 61.7% female). MetS was diagnosed in 14,202 (31%) by NCEP/ATP III criteria, and 17,216 (37.7%) by JIS criteria. Follow-up was available for 44,620 (97.8%, median duration 15.3 years) patients. MetS was associated with increased mortality risk among the obese (hazard ratio, HR: 1.88 [95% CI, 1.79-1.99] and HR: 1.93 [95% CI 1.82-2.04], according to NCEP/ATP III and JIS criteria, respectively) and non-obese individuals (HR: 2.11 [95% CI 1.85-2.40] and 1.7 [95% CI, 1.56-1.85] according to NCEP/ATP III and JIS criteria respectively). Obese patients without MetS had a higher mortality risk than non-obese patients without MetS (HR: 1.16 [95% CI 1.10-1.23] and HR: 1.22 [95%CI 1.15-1.30], respectively in subgroups with NCEP/ATP III and JIS criteria applied). Conclusions MetS is associated with increased all-cause mortality risk in non-obese and obese patients. In patients without MetS obesity remains significantly associated with mortality. The concept of metabolically healthy obesity should be revised